Abstract
Dysregulation of the early stages of B-cell lymphopoiesis, which orchestrates the development of cellular immunity, can induce malignant transformations. Characterizing the gene regulatory network (GRN) driving healthy B-cell development is essential to uncovering the mechanisms behind such malignancies. We generated a comprehensive dataset featuring paired human chromatin accessibility and gene expression data across eight B-cell precursor stages. This study provides the first deep characterization of early B-cell lymphopoiesis, identifying regulatory elements and reconstructing the GRN. We identified well-known regulatory elements alongside new regulons, such as ELK3, which is enriched in pro-B cells and plays a role in cell cycle progression. Single-cell multi-omics further enhanced the resolution of this landscape, identifying MYBL2 and ZNF367 as specific to cycling cell states and CEBPA associated with lymphoid multipotent progenitors (LMPPs). Crucially, this atlas allowed us to identify the cellular origins of B-cell acute lymphoblastic leukemia (B-ALL) subtypes, such as the association of ETV6-RUNX1 with pro-B cells. Our dataset, accessible via the B-rex portal, facilitates a deeper understanding of B-cell differentiation in both health and disease.
Introduction
B cells are the cornerstones of the adaptive immune system. Their journey from hematopoietic stem cells (HSCs) to mature, functional immune cells is a highly regulated biological process. However, this commitment phase is also a period of significant vulnerability; errors in the regulatory program can lead to B-cell acute lymphoblastic leukemia (B-ALL), the most common cancer in children.
Historically, our understanding of human B-cell lymphopoiesis has been limited by a reliance on mouse models or low-resolution human data. There has been a critical lack of a high-definition map of the human "cis-regulatory program"—the complex interplay between open chromatin (the blueprints) and transcription factors (the architects) that dictates B-cell identity. This research addresses this gap by introducing B-rex, the most comprehensive multi-omic atlas of early human B-cell development to date.
Methodology and Data Integration
To map the regulatory landscape, the researchers employed a sophisticated multi-omic approach combining bulk and single-cell analysis:
- Paired Bulk Profiling: The team isolated eight distinct cell subpopulations, ranging from HSCs to Naive B cells, from 13 healthy donors. They performed simultaneous RNA-Seq (transcriptome) and ATAC-Seq (chromatin accessibility) on these populations, resulting in 79 RNA-Seq and 78 ATAC-Seq profiles.
- GRN Reconstruction: A computational pipeline was developed to link 105,359 open chromatin regions (OCRs) to 23,454 expressed genes based on spatial proximity and signal correlation. By mapping transcription factor (TF) binding motifs within these regions, they built a network comprising over 377,000 interactions.
- Single-Cell Validation: To capture temporal nuances and transient states, the researchers used single-cell RNA-seq and ATAC-seq on approximately 3,000 cells per omic layer from human bone marrow.
- Clinical Integration: The healthy B-cell atlas was cross-referenced with transcriptomic data from 1,223 B-ALL patients and Genome-Wide Association Study (GWAS) risk loci to identify the cellular origins of malignant transformations.
Key Insights into B-Cell Regulation
The "Enhancer-First" Rule
A pivotal discovery of this study is that modifications in chromatin accessibility at enhancer regions often precede changes in gene expression. This "enhancer-first" phenomenon suggests that chromatin priming acts as a primary driver, preparing the genome for the transcriptional shifts necessary for B-cell commitment.
Discovery of New Regulatory Players
The study identified several novel regulators of B-cell development:
- ELK3: Identified as a critical transcription factor in pro-B cells. While previously known as an oncogene in other contexts, this work highlights its role in healthy B-cell expansion and its elevated activity in specific B-ALL subtypes.
- MLXIP: Found to be a novel regulator of EBF1, a master gene in B-cell identity.
- Cycling State Regulons: Single-cell analysis revealed MYBL2 and ZNF367 as specific regulators of cycling cell states, while CEBPA was associated with lymphoid multipotent progenitors (LMPPs).
Implications for B-Cell Acute Lymphoblastic Leukemia
By overlapping the healthy B-cell regulatory map with clinical data, the researchers were able to pinpoint the "inflection points" where healthy development veers toward malignancy.
The study revealed that different B-ALL subtypes originate at distinct stages of B-cell development. For instance, ETV6-RUNX1 fusions—a common driver of childhood leukemia—are specifically enriched in the pro-B cell stage. Conversely, MEF2D fusions are more closely associated with the pre-B stage. Furthermore, the research successfully linked B-ALL susceptibility SNPs (such as rs17481869) to specific open chromatin regions in pro-B cells, providing a mechanistic explanation for how non-coding genetic variants contribute to disease risk.
Conclusion and Future Directions
The B-rex atlas provides a foundational resource for the immunology and oncology communities. By mapping the healthy regulatory landscape, researchers can now better interpret the "missteps" that lead to B-ALL. While the study provides a massive correlative map, the authors acknowledge that functional validation—using tools like CRISPR to prove the causality of newly identified enhancers—is the necessary next step.
The authors have made this resource publicly available through the B-rex web interface, allowing researchers worldwide to explore these complex regulatory networks and accelerate the discovery of new therapeutic targets.
Summary updated